Using Science to Navigate the Global Regulatory Maze
Brought to you by DIA in cooperation with
Achieving successful outcomes in a complex regulatory landscape can be challenging, especially when caught in the maze of regulatory agency requirements from varying countries. For many pharmaceutical, biotech and medical device companies with products at varying stages of development, reaching regulatory milestones is a critical path for success. Scientific interpretation and proper presentation of data generated by Sponsors is THE key to succeeding with the FDA and EMA.
- What is "good science"?
- What is "bad science"?
- How to interpret and present “good science” in a way that will result in success with the regulatory agencies
Upon completion of the on demand webinar, participants will have a better understanding of:
- Define good vs. bad science
- Understand the importance of scientific data interpretation and presentation
- Understand how to use science to guide you through the regulatory hurdles and milestones with the FDA and EMA
Continuing Education Credits are not available for this event.